Olivier; Berend
Patent Applications and Registrations
Patent applications and USPTO patent grants for Olivier; Berend.The latest application filed is for "serotonergic agent and 5-ht1a-receptor antagonist".
- Olivier; Berend - LELYSTAD NL
- Olivier, Berend - Lelytstad NL
- Olivier; Berend - Weesp NL
| Patent | Date |
|---|---|
| Serotonergic Agent And 5-ht1a-receptor Antagonist App 20220265641 - Waldinger; Marcel David ; et al. | 2022-08-25 |
| Treatment for a attention-deficit hyperactivity disorder App 20050004105 - Leahy, Emer ; et al. | 2005-01-06 |
| Bibyclic heteroacrylpiperazine derivatives having psychotropic activity, and pharmaceutical compositions containing these derivatives Grant 5,424,313 - Hartog , et al. June 13, 1 | 1995-06-13 |
| 3,4-dehydropiperidine derivatives having psychotropic activity Grant 5,296,497 - Hartog , et al. March 22, 1 | 1994-03-22 |
| Method of treating psychotropic conditions employing substituted piperazine compounds Grant 4,782,061 - Kruse , et al. November 1, 1 | 1988-11-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 